These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 22114474)

  • 21. Preparation and in vitro/in vivo evaluation of gliclazide loaded Eudragit nanoparticles as a sustained release carriers.
    Devarajan PV; Sonavane GS
    Drug Dev Ind Pharm; 2007 Feb; 33(2):101-11. PubMed ID: 17454041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease.
    Patel MM; Amin AF
    Pharm Dev Technol; 2013; 18(2):390-400. PubMed ID: 22304735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fabrication and in vivo evaluation of highly pH-responsive acrylic microparticles for targeted gastrointestinal delivery.
    Kendall RA; Alhnan MA; Nilkumhang S; Murdan S; Basit AW
    Eur J Pharm Sci; 2009 Jun; 37(3-4):284-90. PubMed ID: 19491017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of pH-responsive Eudragit S100-functionalized silk fibroin nanoparticles as a prospective drug delivery system.
    Pham DT; Nguyen DXT; Nguyen NY; Nguyen TTL; Nguyen TQC; Tu AVT; Nguyen NH; Thuy BTP
    PLoS One; 2024; 19(5):e0303177. PubMed ID: 38781182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, Preparation, and Evaluation of Enteric Coating Formulation of HPMC and Eudragit L100 on Carboxylated Agarose Hydrogel by Using Drug Tartrazine.
    Khan MJ; Huang WC; Akhlaq M; Raza S; Hamadou AH; Yuning G; Sun J; Mao X
    Biomed Res Int; 2022; 2022():1042253. PubMed ID: 35127935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Properties of melt extruded enteric matrix pellets.
    Schilling SU; Shah NH; Waseem Malick A; McGinity JW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):352-61. PubMed ID: 19782133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physicochemical characterization of papain entrapped in ionotropically cross-linked kappa-carrageenan gel beads for stability improvement using Doehlert shell design.
    Sankalia MG; Mashru RC; Sankalia JM; Sutariya VB
    J Pharm Sci; 2006 Sep; 95(9):1994-2013. PubMed ID: 16850431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Pullulan-Eudragit® S100 blend microparticles for oral delivery of risedronate: formulation, in vitro evaluation and tableting of blend microparticles.
    de Arce Velasquez A; Ferreira LM; Stangarlin MF; da Silva Cde B; Rolim CM; Cruz L
    Mater Sci Eng C Mater Biol Appl; 2014 May; 38():212-7. PubMed ID: 24656371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chitosan gel containing polymeric nanocapsules: a new formulation for vaginal drug delivery.
    Frank LA; Sandri G; D'Autilia F; Contri RV; Bonferoni MC; Caramella C; Frank AG; Pohlmann AR; Guterres SS
    Int J Nanomedicine; 2014; 9():3151-61. PubMed ID: 25061292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Achieving gastroresistance without coating: Formulation of capsule shells from enteric polymers.
    Barbosa JAC; Al-Kauraishi MM; Smith AM; Conway BR; Merchant HA
    Eur J Pharm Biopharm; 2019 Nov; 144():174-179. PubMed ID: 31541663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formulation optimization of solid dispersion of mosapride hydrochloride.
    Kim HJ; Lee SH; Lim EA; Kim JS
    Arch Pharm Res; 2011 Sep; 34(9):1467-75. PubMed ID: 21975808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and characterization of enteric microparticles by coacervation.
    Thomas S; Chong YN; Chaw CS
    Drug Dev Ind Pharm; 2013 Jul; 39(7):1142-51. PubMed ID: 23003201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and evaluation of pH modulated controlled release matrix systems for colon specific delivery of indomethacin.
    Asghar LF; Chandran S
    Pharmazie; 2008 Oct; 63(10):736-42. PubMed ID: 18972836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies on heart-protecting musk pH-dependent gradient-release pellets].
    Song HT; Guo T; Zhang RH; Ma Y; Li X; Bi KS
    Yao Xue Xue Bao; 2002 Oct; 37(10):812-7. PubMed ID: 12567868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curcumin loaded pH-sensitive nanoparticles for the treatment of colon cancer.
    Prajakta D; Ratnesh J; Chandan K; Suresh S; Grace S; Meera V; Vandana P
    J Biomed Nanotechnol; 2009 Oct; 5(5):445-55. PubMed ID: 20201417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of some formulation variables on the optimization of pH-dependent, colon-targeted, sustained-release mesalamine microspheres.
    El-Bary AA; Aboelwafa AA; Al Sharabi IM
    AAPS PharmSciTech; 2012 Mar; 13(1):75-84. PubMed ID: 22130789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. pH-Sensitive oral insulin delivery systems using Eudragit microspheres.
    Mundargi RC; Rangaswamy V; Aminabhavi TM
    Drug Dev Ind Pharm; 2011 Aug; 37(8):977-85. PubMed ID: 21417605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the feasibility of spray-dried eudragit-trehalose microparticles for enteric drug delivery.
    Bin Karim S; Ordoubadi M; Wang H; Gomez M; Vehring R
    Int J Pharm; 2021 Dec; 610():121264. PubMed ID: 34742827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High precision microfluidic microencapsulation of bacteriophages for enteric delivery.
    Vinner GK; Malik DJ
    Res Microbiol; 2018 Nov; 169(9):522-530. PubMed ID: 29886256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres.
    Rawat M; Saraf S; Saraf S
    AAPS PharmSciTech; 2007 Dec; 8(4):E116. PubMed ID: 18181537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.